StonvexLoading…
StonvexCore line items from AVBC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | Not available | $33.60M | $130.58M | $96.79M | $62.91M |
Operating Income | Not available | $8.19M | $-5.68M | $-13.43M | $-11.48M |
Net Income | Not available | $6.00M | $-3.29M | $-8.62M | $-7.71M |
EPS (Diluted) | $0.35 | $0.32 | $-0.18 | $-0.47 | Not available |
Total Assets | Not available | $2.81B | $2.84B | $2.79B | $2.96B |
Total Liabilities | Not available | $2.42B | $2.46B | $2.41B | $2.77B |
Cash & Equivalents | Not available | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $7.72M | $24.09M | $16.07M | $-7.19M |
Shares Outstanding | Not available | 20.08M | 20.08M | 20.08M | Not available |